We could not find any results for:
Make sure your spelling is correct or try broadening your search.
AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-... AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-02 and ARX-03. The majority of its revenue is generated from DSUVIA product sales in the United States. Show more
AcelRx Announces Rebranding With Name Change to Talphera, Inc. PR Newswire SAN MATEO, Calif., Jan. 9, 2024 Name change to "Talphera" reflects a new era of the Company in partnership with the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0.3325 | 63.0331753555 | 0.5275 | 0.8775 | 0.425 | 133453 | 0.68654436 | CS |
52 | 0.22 | 34.375 | 0.64 | 1.42 | 0.425 | 194641 | 0.8287531 | CS |
156 | -24.74 | -96.640625 | 25.6 | 33.4 | 0.425 | 979443 | 11.86601158 | CS |
260 | -73.34 | -98.8409703504 | 74.2 | 74.2 | 0.425 | 1343935 | 27.41840926 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions